Related Experiment Video
Updated: Jun 17, 2026
16:07
Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Viral TNF inhibitors as potential therapeutics
Masmudur M Rahman1, Alexandra R Lucas, Grant McFadden
1Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Advances in Experimental Medicine and Biology
|January 9, 2010
Summary
Tumor Necrosis Factor (TNF) is a key inflammatory molecule. This review explores virus-encoded TNF inhibitors as potential new therapies for inflammatory diseases, offering alternatives to current treatments.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- The immune system relies on a balance between pro-inflammatory and anti-inflammatory pathways.
- Dysregulation of these pathways, particularly elevated Tumor Necrosis Factor (TNF), drives inflammatory diseases.
- Current anti-TNF therapies, while effective, have limitations and risks.
Purpose of the Study:
- To review known virus-encoded TNF inhibitors.
- To evaluate their potential as alternative or complementary anti-TNF therapies.
- To explore novel therapeutic strategies for TNF-mediated inflammatory conditions.
Main Methods:
- Literature review of viral mechanisms targeting TNF.
- Analysis of viral protein functions in modulating TNF signaling.
- Evaluation of existing data on viral TNF inhibitors for therapeutic potential.
Main Results:
- Viruses encode diverse inhibitors targeting TNF, its receptors, or downstream pathways.
- These viral molecules represent a distinct approach to modulating TNF biology.
- Understanding these viral mechanisms can inform the development of new therapeutic agents.
Conclusions:
- Virus-encoded TNF inhibitors show promise as novel therapeutic strategies.
- They may offer alternatives or adjuncts to current anti-TNF treatments.
- Further research into these viral modulators could lead to innovative treatments for inflammatory diseases.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...